Drug
Prasinezumab
Prasinezumab: highest development phase Phase 3, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Prasinezumab NCT07174310 | Phase 3 | Parkinson's Disease |
Latest
No recent events.
Follow Prasinezumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.